PubMed
Kisspeptin signaling in reproductive biology
Pinilla et al., 2012
Kisspeptin-10
Neuropeptide signaling regulator of the GnRH axis, studied for reproductive endocrinology.
Overall check-ins
Trackers & reports
Overview
Neuropeptide signaling regulator of the GnRH axis, studied for reproductive endocrinology.
Community
From check-in ratings — separate from side effects logged below. Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.
Favorable 3% · Mixed 4% · Unfavorable overall 93%
Benefits users selected when logging a favorable or mixed check-in.
Median bucket: 200–400 mcg · Most common: 200–400 mcg
Reports span 100–1000 mcg
Anonymized self-reports from PeptIQ users — not prescribing guidance. Buckets group similar logged amounts; open-ended top buckets mean “at least” that dose.
Among repeat reporters, 78% said they felt similar to their last entry, 22% more positive, and 0% more negative.
Overall, repeat reporters leaned more positive than their previous entry.
Median gap between entries: 160 days · Based on 23 repeat reporters
Research
PubMed
Pinilla et al., 2012
PubMed
Skorupskaite et al., 2018
ClinicalTrials.gov
ClinicalTrials.gov, 2024
PubMed
Abreu et al., 2016
PubMed
Hameed et al., 2011
Tools
More ways to learn about Kisspeptin from observational PeptIQ data.
Compare with
Related peptides
Help
This page summarizes 29 anonymized self-reports from PeptIQ users who track Kisspeptin, including commonly reported effects and co-tracked peptides. These are observational patterns, not clinical outcomes.
PeptIQ separates overall check-in ratings (favorable, mixed, or unfavorable) from logged side effects like nausea or fatigue. Users often report benefits and side effects in the same check-in — a high experience score does not mean zero side effects were noted.
5 sources are linked on this page, including PubMed articles, clinical trial registries, and FDA labels where applicable. Citations describe published research — not recommendations.
This wiki does not assess safety or recommend use. Kisspeptin is listed as Research Only. Consult a licensed clinician for personal medical decisions.
This wiki summarizes observational community reports and linked citations for Kisspeptin. It does not assert therapeutic benefits. See the cited research list on this page and the educational profile for Kisspeptin for study-level context — not medical advice.
Kisspeptin is listed in PeptIQ as Research Only. Regulatory status varies by jurisdiction and can change. This wiki does not provide legal advice; check current FDA and local rules and talk with a licensed clinician or counsel for personal decisions.
Safety data quality for Kisspeptin varies widely by compound and study design. PeptIQ does not establish a risk profile here. Review primary literature, product labeling where applicable, and clinician guidance. Community self-reports are not a substitute for clinical evidence.
This page links 5 indexed sources for Kisspeptin. Evidence maturity differs by application — some peptides have large human programs, others are mostly preclinical. Treat citation counts as literature volume, not proof of efficacy.